Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.1.1 POLITICAL FACTORS
4.1.2 ECONOMIC FACTORS
4.1.3 SOCIAL FACTORS
4.1.4 TECHNOLOGICAL FACTORS
4.1.5 LEGAL FACTORS
4.1.6 ENVIRONMENTAL FACTORS
4.2 PORTER’S FIVE FORCES
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 BARGAINING POWER OF SUPPLIERS
4.2.3 BARGAINING POWER OF BUYERS
4.2.4 THREAT OF SUBSTITUTES
4.2.5 COMPETITIVE RIVALRY
4.3 INNOVATION STRATEGIES
4.3.1 KEY INNOVATION STRATEGIES
4.3.2 EMERGING DELIVERY TECHNIQUES
4.3.3 STRATEGIC IMPLICATIONS
4.3.4 CONCLUSION
4.4 INNOVATION STRATEGIES
4.4.1 KEY INNOVATION STRATEGIES
4.4.2 EMERGING DELIVERY TECHNIQUES
4.4.3 STRATEGIC IMPLICATIONS
4.4.4 CONCLUSION
4.5 SUPPLY CHAIN ANALYSIS
4.5.1 OVERVIEW
4.5.2 RAW MATERIAL AVAILABILITY
4.5.3 MANUFACTURING CAPACITY
4.5.4 LOGISTICS AND LAST-MILE HURDLES
4.5.5 PRICING MODELS AND MARKET POSITIONING
4.6 RISK AND MITIGATION
4.7 VENDOR SELECTION DYNAMICS
4.7.1 PRODUCT QUALITY AND REGULATORY EXCELLENCE
4.7.2 PLASMA SUPPLY SECURITY AND SUPPLY CHAIN RESILIENCE
4.7.3 CLINICAL PERFORMANCE, INDICATION BREADTH, AND INNOVATION
4.7.4 COST STRUCTURE, CONTRACT FLEXIBILITY, AND REIMBURSEMENT ALIGNMENT
4.7.5 GEOGRAPHIC FOOTPRINT AND LOCAL MARKET SUPPORT
4.7.6 ETHICAL PLASMA SOURCING, ESG COMMITMENTS, AND TRANSPARENCY
4.7.7 STRATEGIC PARTNERSHIPS AND LONG-TERM VALUE CREATION
4.7.8 CONCLUSION
5 TARIFFS & IMPACT ON THE MARKET
5.1 CURRENT TARIFF RATES IN TOP-5 COUNTRY MARKETS
5.2 OUTLOOK: LOCAL PRODUCTION VS. IMPORT RELIANCE
5.3 VENDOR SELECTION CRITERIA DYNAMICS
5.4 IMPACT ON SUPPLY CHAIN
5.4.1 PLASMA COLLECTION & RAW MATERIAL AVAILABILITY
5.4.2 MANUFACTURING AND FRACTIONATION
5.4.3 LOGISTICS AND DISTRIBUTION
5.4.4 PRICING AND MARKET POSITIONING
5.5 INDUSTRY PARTICIPANTS: PROACTIVE MOVES
5.5.1 SUPPLY CHAIN OPTIMIZATION
5.5.2 STRATEGIC PARTNERSHIPS & JOINT VENTURES
5.6 IMPACT ON PRICES
5.7 REGULATORY INCLINATION
5.7.1 GCC TRADE ALIGNMENT & FTAS
5.7.2 SPECIAL ZONES AND RE-EXPORT MODELS
5.7.3 LOCAL SUBSIDY & POLICY RESPONSE
5.7.4 DOMESTIC COURSE OF CORRECTION
6 REGULATION COVERAGE
7 MARKET OVERVIEW
7.1 DRIVER
7.1.1 RISING PREVALENCE OF RARE AND CHRONIC DISEASES
7.1.2 EXPANDING GERIATRIC POPULATION
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN PLASMA FRACTIONATION
7.1.4 GOVERNMENT AND INSTITUTIONAL SUPPORT
7.2 RESTRAINTS
7.2.1 HIGH COST AND COMPLEX MANUFACTURING PROCESS
7.2.2 LACK OF PLASMA SUPPLY AND DONOR
7.3 OPPORTUNITIES
7.3.1 ADVANCEMENTS IN PLASMA PROCESSING TECHNOLOGIES TO ENHANCE YIELD AND REDUCE COSTS
7.3.2 REIMBURSEMENT FRAMEWORKS AND INCREASED GOVERNMENTAL FOCUS ON RARE DISEASE TREATMENT
7.3.3 STRATEGIC ALLIANCES, MERGERS, AND ACQUISITIONS TO STRENGTHEN EUROPE MARKET PENETRATION
7.4 CHALLENGES
7.4.1 COMPETITIVE PRESSURE FROM RECOMBINANT AND ALTERNATIVE BIOLOGICAL THERAPIES
7.4.2 INFRASTRUCTURE LIMITATIONS IN COLD CHAIN LOGISTICS IMPACTING PRODUCT DISTRIBUTION
8 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 IMMUNOGLOBULINS
8.3 COAGULATION FACTORS
8.4 ALBUMIN
8.5 PROTEASE INHIBITORS
8.6 MONOCLONAL ANTIBODIES
8.7 OTHER PLASMA DERIVED PROTEINS
8.8 EUROPE IMMUNOGLOBULINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.8.1 NORTH AMERICA
8.8.2 EUROPE
8.8.3 ASIA-PACIFIC
8.8.4 SOUTH AMERICA
8.8.5 MIDDLE EAST AND AFRICA
8.9 EUROPE COAGULATION FACTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.9.1 NORTH AMERICA
8.9.2 EUROPE
8.9.3 ASIA-PACIFIC
8.9.4 SOUTH AMERICA
8.9.5 MIDDLE EAST AND AFRICA
8.1 EUROPE ALBUMIN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.10.1 NORTH AMERICA
8.10.2 EUROPE
8.10.3 ASIA-PACIFIC
8.10.4 SOUTH AMERICA
8.10.5 MIDDLE EAST AND AFRICA
8.11 EUROPE PROTEASE INHIBITORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.11.1 NORTH AMERICA
8.11.2 EUROPE
8.11.3 ASIA-PACIFIC
8.11.4 SOUTH AMERICA
8.11.5 MIDDLE EAST AND AFRICA
8.12 EUROPE MONOCLONAL ANTIBODIES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.12.1 NORTH AMERICA
8.12.2 EUROPE
8.12.3 ASIA-PACIFIC
8.12.4 SOUTH AMERICA
8.12.5 MIDDLE EAST AND AFRICA
8.13 EUROPE OTHER PLASMA DERIVED PROTEINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.13.1 NORTH AMERICA
8.13.2 EUROPE
8.13.3 ASIA-PACIFIC
8.13.4 SOUTH AMERICA
8.13.5 MIDDLE EAST AND AFRICA
9 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 IMMUNOLOGY
9.3 HAEMATOLOGY
9.4 CRITICAL CARE
9.5 NEUROLOGY
9.6 PULMONOLOGY
9.7 HAEMATO-ONCOLOGY
9.8 RHEUMATOLOGY
9.9 OTHER APPLICATIONS
9.1 EUROPE IMMUNOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.10.1 NORTH AMERICA
9.10.2 EUROPE
9.10.3 ASIA-PACIFIC
9.10.4 SOUTH AMERICA
9.10.5 MIDDLE EAST AND AFRICA
9.11 EUROPE HAEMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.11.1 NORTH AMERICA
9.11.2 EUROPE
9.11.3 ASIA-PACIFIC
9.11.4 SOUTH AMERICA
9.11.5 MIDDLE EAST AND AFRICA
9.12 EUROPE CRITICAL CARE IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.12.1 NORTH AMERICA
9.12.2 EUROPE
9.12.3 ASIA-PACIFIC
9.12.4 SOUTH AMERICA
9.12.5 MIDDLE EAST AND AFRICA
9.13 EUROPE NEUROLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.13.1 NORTH AMERICA
9.13.2 EUROPE
9.13.3 ASIA-PACIFIC
9.13.4 SOUTH AMERICA
9.13.5 MIDDLE EAST AND AFRICA
9.14 EUROPE PULMONOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.14.1 NORTH AMERICA
9.14.2 EUROPE
9.14.3 ASIA-PACIFIC
9.14.4 SOUTH AMERICA
9.14.5 MIDDLE EAST AND AFRICA
9.15 EUROPE HAEMATO-ONCOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.15.1 NORTH AMERICA
9.15.2 EUROPE
9.15.3 ASIA-PACIFIC
9.15.4 SOUTH AMERICA
9.15.5 MIDDLE EAST AND AFRICA
9.16 EUROPE RHEUMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.16.1 NORTH AMERICA
9.16.2 EUROPE
9.16.3 ASIA-PACIFIC
9.16.4 SOUTH AMERICA
9.16.5 MIDDLE EAST AND AFRICA
9.17 EUROPE OTHER APPLICATIONS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.17.1 NORTH AMERICA
9.17.2 EUROPE
9.17.3 ASIA-PACIFIC
9.17.4 SOUTH AMERICA
9.17.5 MIDDLE EAST AND AFRICA
10 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY
10.1 OVERVIEW
10.2 ION EXCHANGE CHROMATOGRAPHY
10.3 AFFINITY CHROMATOGRAPHY
10.4 CRYOPRECIPITATION
10.5 ULTRAFILTRATION
10.6 MICROFILTRATION
10.7 EUROPE ION EXCHANGE CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.7.1 NORTH AMERICA
10.7.2 EUROPE
10.7.3 ASIA-PACIFIC
10.7.4 SOUTH AMERICA
10.7.5 MIDDLE EAST AND AFRICA
10.8 EUROPE AFFINITY CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.8.1 NORTH AMERICA
10.8.2 EUROPE
10.8.3 ASIA-PACIFIC
10.8.4 SOUTH AMERICA
10.8.5 MIDDLE EAST AND AFRICA
10.9 EUROPE CRYOPRECIPITATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.9.1 NORTH AMERICA
10.9.2 EUROPE
10.9.3 ASIA-PACIFIC
10.9.4 SOUTH AMERICA
10.9.5 MIDDLE EAST AND AFRICA
10.1 EUROPE ULTRAFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.10.1 NORTH AMERICA
10.10.2 EUROPE
10.10.3 ASIA-PACIFIC
10.10.4 SOUTH AMERICA
10.10.5 MIDDLE EAST AND AFRICA
10.11 EUROPE MICROFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.11.1 NORTH AMERICA
10.11.2 EUROPE
10.11.3 ASIA-PACIFIC
10.11.4 SOUTH AMERICA
10.11.5 MIDDLE EAST AND AFRICA
11 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE
11.1 OVERVIEW
11.2 MODERN
11.3 TRADITIONAL PLASMA FRACTIONATION
11.4 EUROPE MODERN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.4.1 NORTH AMERICA
11.4.2 EUROPE
11.4.3 ASIA-PACIFIC
11.4.4 SOUTH AMERICA
11.4.5 MIDDLE EAST AND AFRICA
11.5 EUROPE TRADITIONAL PLASMA FRACTIONATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.5.1 NORTH AMERICA
11.5.2 EUROPE
11.5.3 ASIA-PACIFIC
11.5.4 SOUTH AMERICA
11.5.5 MIDDLE EAST AND AFRICA
12 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS & CLINICS
12.3 RESEARCH LABS
12.4 ACADEMIC INSTITUTES
12.5 OTHERS
12.6 EUROPE HOSPITALS & CLINICS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.6.1 NORTH AMERICA
12.6.2 EUROPE
12.6.3 ASIA-PACIFIC
12.6.4 SOUTH AMERICA
12.6.5 MIDDLE EAST AND AFRICA
12.7 EUROPE RESEARCH LABS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.7.1 NORTH AMERICA
12.7.2 EUROPE
12.7.3 ASIA-PACIFIC
12.7.4 SOUTH AMERICA
12.7.5 MIDDLE EAST AND AFRICA
12.8 EUROPE ACADEMIC INSTITUTES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.8.1 NORTH AMERICA
12.8.2 EUROPE
12.8.3 ASIA-PACIFIC
12.8.4 SOUTH AMERICA
12.8.5 MIDDLE EAST AND AFRICA
12.9 EUROPE OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.9.1 NORTH AMERICA
12.9.2 EUROPE
12.9.3 ASIA-PACIFIC
12.9.4 SOUTH AMERICA
12.9.5 MIDDLE EAST AND AFRICA
13 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
13.5 EUROPE DIRECT TENDERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.5.1 NORTH AMERICA
13.5.2 EUROPE
13.5.3 ASIA-PACIFIC
13.5.4 SOUTH AMERICA
13.5.5 MIDDLE EAST AND AFRICA
13.6 EUROPE THIRD PARTY DISTRIBUTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.6.1 NORTH AMERICA
13.6.2 EUROPE
13.6.3 ASIA-PACIFIC
13.6.4 SOUTH AMERICA
13.6.5 MIDDLE EAST AND AFRICA
13.7 EUROPE OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.7.1 NORTH AMERICA
13.7.2 EUROPE
13.7.3 ASIA-PACIFIC
13.7.4 SOUTH AMERICA
13.7.5 MIDDLE EAST AND AFRICA
14 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION
14.1 EUROPE
14.1.1 GERMANY
14.1.2 FRANCE
14.1.3 UNITED KINGDOM
14.1.4 ITALY
14.1.5 SPAIN
14.1.6 RUSSIA
14.1.7 SWITZERLAND
14.1.8 TURKEY
14.1.9 NETHERLANDS
14.1.10 POLAND
14.1.11 SWEDEN
14.1.12 DENMARK
14.1.13 BELGIUM
14.1.14 IRELAND
14.1.15 NORWAY
14.1.16 FINLAND
14.1.17 REST OF EUROPE
15 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 CSL
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 GRIFOLS, S.A.
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 OCTAPHARMA AG
17.4.1 COMPANY SNAPSHOT
17.4.2 COMPANY SHARE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 KEDRION
17.5.1 COMPANY SNAPSHOT
17.5.2 COMPANY SHARE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 ADMA BIOLOGICS, INC
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 AEGROS
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 BHARAT SERUMS
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIOTEST AG.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 FRESENIUS KABI AG
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 GC BIOPHARMA CORPORATE
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 ICHOR
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 INTAS PHARMACEUTICALS LTD.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 KAMADA PHARMACEUTICALS
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 KM BIOLOGICS
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 LFB
17.16.1 COMPANY SNAPSHOT
17.16.2 THERAPY PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 PLASMAGEN BIOSCIENCES PVT. LTD.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 PROLIANT HEALTH & BIOLOGICALS
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 PROMEA
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 RELIANCE LIFE SCIENCES.
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 SICHUAN YUANDA SHYUANG PHARMACEUTICAL CO., LTD.
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SK PLASMA
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 SYNTHAVERSE S. A.
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 TAIBANG BIO GROUP CO., LTD
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 VIRCHOW BIOTECH
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 2 EUROPE IMMUNOGLOBULINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 3 EUROPE COAGULATION FACTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 4 EUROPE ALBUMIN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 5 EUROPE PROTEASE INHIBITORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 6 EUROPE MONOCLONAL ANTIBODIES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 7 EUROPE OTHER PLASMA DERIVED PROTEINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 8 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 9 EUROPE IMMUNOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 10 EUROPE HAEMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 11 EUROPE CRITICAL CARE IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 12 EUROPE NEUROLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 13 EUROPE PULMONOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 14 EUROPE HAEMATO-ONCOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 15 EUROPE RHEUMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 16 EUROPE OTHER APPLICATIONS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 17 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 18 EUROPE ION EXCHANGE CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 19 EUROPE AFFINITY CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 20 EUROPE CRYOPRECIPITATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 21 EUROPE ULTRAFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 22 EUROPE MICROFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 23 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 24 EUROPE MODERN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 25 EUROPE TRADITIONAL PLASMA FRACTIONATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 26 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 27 EUROPE HOSPITALS & CLINICS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 28 EUROPE RESEARCH LABS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 29 EUROPE ACADEMIC INSTITUTES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 30 EUROPE OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 31 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 32 EUROPE DIRECT TENDERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 33 EUROPE THIRD PARTY DISTRIBUTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 34 EUROPE OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 35 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 36 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 37 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 38 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 39 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 40 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 41 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 42 GERMANY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 43 GERMANY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 44 GERMANY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 45 GERMANY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 46 GERMANY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 47 GERMANY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 48 FRANCE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 49 FRANCE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 50 FRANCE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 51 FRANCE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 52 FRANCE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 53 FRANCE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 54 UNITED KINGDOM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 55 UNITED KINGDOM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 56 UNITED KINGDOM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 57 UNITED KINGDOM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 58 UNITED KINGDOM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 59 UNITED KINGDOM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 60 ITALY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 61 ITALY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 62 ITALY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 63 ITALY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 64 ITALY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 65 ITALY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 66 SPAIN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 67 SPAIN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 68 SPAIN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 69 SPAIN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 70 SPAIN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 71 SPAIN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 72 RUSSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 73 RUSSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 74 RUSSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 75 RUSSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 76 RUSSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 77 RUSSIA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 78 SWITZERLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 79 SWITZERLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 80 SWITZERLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 81 SWITZERLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 82 SWITZERLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 83 SWITZERLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 84 TURKEY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 85 TURKEY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 86 TURKEY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 87 TURKEY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 88 TURKEY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 89 TURKEY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 90 NETHERLANDS BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 91 NETHERLANDS BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 92 NETHERLANDS BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 93 NETHERLANDS BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 94 NETHERLANDS BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 95 NETHERLANDS BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 96 POLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 97 POLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 98 POLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 99 POLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 100 POLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 101 POLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 102 SWEDEN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 103 SWEDEN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 104 SWEDEN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 105 SWEDEN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 106 SWEDEN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 107 SWEDEN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 108 DENMARK BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 109 DENMARK BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 110 DENMARK BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 111 DENMARK BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 112 DENMARK BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 113 DENMARK BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 114 BELGIUM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 115 BELGIUM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 116 BELGIUM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 117 BELGIUM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 118 BELGIUM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 119 BELGIUM BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 120 IRELAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 121 IRELAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 122 IRELAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 123 IRELAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 124 IRELAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 125 IRELAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 126 NORWAY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 127 NORWAY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 128 NORWAY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 129 NORWAY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 130 NORWAY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 131 NORWAY BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 132 FINLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 133 FINLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 134 FINLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 135 FINLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 136 FINLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 137 FINLAND BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 138 REST OF EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 139 REST OF EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 140 REST OF EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 141 REST OF EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 142 REST OF EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 143 REST OF EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: SEGMENTATION
FIGURE 2 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: SEGMENTATION
FIGURE 11 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 NORTH AMEIRCA IS EXPECTED TO DOMINATE THE MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 14 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT (2024)
FIGURE 15 RISING PREVELANCE OF RARE & CHRONIC DISEASES IS EXPECTED TO DRIVE THE EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 16 IMMUNOGLOBULINS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET IN THE FORECAST PERIOD OF 2026 & 2033
FIGURE 17 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES FOR THE EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET
FIGURE 19 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, 2025
FIGURE 20 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, 2026 TO 2033 (USD THOUSAND)
FIGURE 21 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, CAGR (2026- 2033)
FIGURE 22 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 23 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, 2025
FIGURE 24 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, 2026 TO 2033 (USD THOUSAND)
FIGURE 25 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, CAGR (2026- 2033)
FIGURE 26 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, 2025
FIGURE 28 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, 2026 TO 2033 (USD THOUSAND)
FIGURE 29 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, CAGR (2026- 2033)
FIGURE 30 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 31 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, 2025
FIGURE 32 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, 2026 TO 2033 (USD THOUSAND)
FIGURE 33 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, CAGR (2026- 2033)
FIGURE 34 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, LIFELINE CURVE
FIGURE 35 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, 2025
FIGURE 36 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, 2026 TO 2033 (USD THOUSAND)
FIGURE 37 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, CAGR (2026- 2033)
FIGURE 38 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 39 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2025
FIGURE 40 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2026 TO 2033 (USD THOUSAND)
FIGURE 41 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2026- 2033)
FIGURE 42 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 EUROPE BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: SNAPSHOT (2025)
FIGURE 44 EUROPE BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: COMPANY SHARE 2025 (%)
